223 related articles for article (PubMed ID: 34429320)
1. Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases.
Chiang TP; Connolly CM; Ruddy JA; Boyarsky BJ; Alejo JL; Werbel WA; Massie A; Christopher-Stine L; Garonzik-Wang J; Segev DL; Paik JJ
Ann Rheum Dis; 2021 Oct; 80(10):1365-1366. PubMed ID: 34429320
[No Abstract] [Full Text] [Related]
2. Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases.
Boyarsky BJ; Ruddy JA; Connolly CM; Ou MT; Werbel WA; Garonzik-Wang JM; Segev DL; Paik JJ
Ann Rheum Dis; 2021 Aug; 80(8):1098-1099. PubMed ID: 33757968
[No Abstract] [Full Text] [Related]
3. Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'.
Smerilli G; Cipolletta E; Moscioni E; Francioso F; Risa AM; Maccarrone V; Zompa D; Di Matteo A; Di Carlo M; De Angelis R; Salaffi F; Filippucci E; Grassi W
Ann Rheum Dis; 2021 Oct; 80(10):e168. PubMed ID: 33962960
[No Abstract] [Full Text] [Related]
4. Response to: 'Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'' by Smerilli
Priori R; Pellegrino G; Colafrancesco S; Alessandri C; Ceccarelli F; Di Franco M; Riccieri V; Scrivo R; Sili Scavalli A; Spinelli FR; Conti F
Ann Rheum Dis; 2021 Oct; 80(10):e169. PubMed ID: 33962963
[No Abstract] [Full Text] [Related]
5. SARS-CoV-2 vaccine 
